| | | 20,000+ Fresh Resumes Monthly | |
|
|
| |
Click here or scroll down to respond to this candidateCURRICULUM VITAECandidate's Name
PROFESSIONAL SUMMARYExperienced healthcare professional with strong leadership and relationship-building skillsDedicated to improving accuracy and efficiency of proofreading operations with a critical and disciplined approach to the review of all healthcare, medical and scientific literature and documentsAble to work with minimal direction to solve problems, meet deadlines and respond to supervisory and management inquiries.PERSONAL DATAAddress: 51 Prospect Road Centerport, NY 11721-1131Telephone: PHONE NUMBER AVAILABLEE-mail: EMAIL AVAILABLEEDUCATIONA. Union University, College of Pharmacy, Albany, New York,B.S. in Pharmacy, 1965-70B. University of Michigan, College of Pharmacy, Ann Arbor,Michigan, Pharm. D. (Doctor of Pharmacy), 1971-72C. University of Michigan, College of Pharmacy, Ann Arbor,Michigan, Ph.D. (Radiopharmaceutical Science), 1973-76D. Southern Vermont College, Bennington, VermontDoctor of Law (Honorary), 1994PROFESSIONAL APPOINTMENTSA. Chairman, New York State Board of Pharmacy, 1989-1990B. Member, Executive Committee, New York State Board ofPharmacy, 1987-1990C. Member, New York State Board of Pharmacy, State EducationDepartment, Albany, New York, 1981-1991CORPORATE & ACADEMIC POSITIONSA.Business/Executive Consultant, Freelance Writer/CopyeditorJanuary 1996 PresentB.Founder/ Chairman of the Board of DirectorsPharmaDynamics, Inc., Centerport, NY, September 1996-PresentC.President and Chairman of the Board of DirectorsHealth Management, Inc., Ronkonkoma, NY, May 1985-Jan 1996D. President and Director, Nuclear & Genetic Technology, Inc.,Melville, NY, January 1982 - May 1985E. Consultant in Radiopharmaceutical Science, Mallinckrodt, Inc.,St. Louis, MO, April 1986- April 1989F. Assistant Professor of Radiology, School of Medicine, StateUniversity of New York, Stony Brook, NY, 1980-81G. Director of Nuclear Pharmacy, University Hospital, State Universityof New York, Stony Brook, NY, 1980-81H. Assistant Professor of Radiopharmaceutical Science, College ofPharmacy and Allied Health Professionals, Northeastern University,Boston, MA, 1976-80I. Assistant Radiation Safety Officer, Northeastern University,Boston, MA, (NRC License No. 20-06432-07), 1979-80J. Chief of Nuclear Pharmacy Services, Nuclear MedicineDept, New England Medical Center Hospital, Boston, MA, 1977-80K. Assistant Professor of Radiology, Tufts Medical School, Boston,MA, 1979-80L. Adjunct Assistant Professor of Nuclear Medicine, University ofMassachusetts Medical School, Worcester, MA, 1977-80M. Consultant Nuclear Pharmacist, Radiopharmacy Department,Harvard Medical School Department of Radiology, Joint Programin Nuclear Medicine, Childrens Hospital Medical Center, Boston,MA, 1976-77N. Teaching Assistant in Nuclear Pharmacy, University of Michigan,Ann Arbor, MI, 1974-75O. Teaching Assistant in Pharmaceutical Dispensing, University ofMichigan, Ann Arbor, MI, 1973-74P. American Society of Hospital Pharmacy Accredited Residency inHospital and Clinical Pharmacy, University Hospital, Ann Arbor,Michigan, 1972-73Q. Instructor in Clinical Pharmacy Rounds, Mott Childrens Hospital,Ann Arbor, MI, 1973R. Registered Pharmacist, Peoples Drug Store #60, Arlington,VA, 1970-71MEMBERSHIP IN PROFESSIONAL ORGANIZATIONSA. American Pharmaceutical Association, 1965-2000B. National Association of Boards of Pharmacy, 1981-96C. American Pharmaceutical Association, Academy of PharmacyPractice - Section on Nuclear Pharmacy, 1976-2000D. Society of Nuclear Medicine, 1975-2000E. Radiopharmaceutical Science Council, Society of NuclearMedicine, 1975-1995F. American Pharmaceutical Association, Academy of PharmaceuticalSciences 1974-80G. American Association of Colleges of Pharmacy, 1979-82H. Southeastern Michigan Society of Hospitals Pharmacists, 1975-77I. Phi Delta Chi Pharmacy Fraternity, 1966-PresentPOSITIONS HELD IN ABOVE ORGANIZATIONSA. Member, Nominations Committee, Section on Nuclear Pharmacy,Academy of Pharmacy Practice, American PharmaceuticalAssociation, 1977-78B. Chairman, Nominations Committee, Section on Nuclear Pharmacy,Academy of Pharmacy Practice, American PharmaceuticalAssociation, 1978-79C. Member, Program Committee, Section on Nuclear Pharmacy,Academy of Pharmacy Practice, American PharmaceuticalAssociation, 1979-80D. Chairman, Program Committee, Section on Nuclear Pharmacy,Academy of Pharmacy Practice, American PharmaceuticalAssociation, 1980-81E. Chairman, Section on Nuclear Pharmacy, Academy of Pharmacy Practice, American Pharmaceutical Association, 1978-79F. Chairman, Ad Hoc Nuclear Pharmacy Committee, NationalAssociations of Boards of Pharmacy, 1981-82HONORSA. Rho Chi Professional Pharmacy Honor SocietyB. Sigma Xi Honorary Scientific SocietyC. Phi Lambda Upsilon Honorary Chemical SocietyINVITED SYMPOSIA, PAPERS AND LECTURESA. Dosimetry of Autologous Baboon Platelets Labeled with In-111Oxine, Society of Nuclear Medicine Annual Meeting, Atlanta,Georgia, June 1979B A Sterile Technique for Labeling Platelets with In-111 Oxine,American Pharmaceutical Association, Academy of PharmacyPractice, Section on Nuclear Pharmacy, Annual Meeting, Anaheim,California, April 1979C. A Model for the Study of the Dynamic Sequence of HealingPatterns in Reconstructed Arterial Surfaces, New England SocietyMeeting, Dixville Notch, New Hampshire, September 1978D. Nuclear Pharmacy Practice: Who, What, Where and Why?Presented at Northeastern University continuing education courseRadiopharmaceuticals, Radiographic Agents and Radioimmuno-assay: Principals and Applications, Marriott Hotel, Newton,Massachucetts, November 1977E. Recent Advances in Nuclear Medicine Myocardial Imaging,Regional Postgraduate Medical Course, Central Maine GeneralHospital, Lewiston, Maine, October 1977F. Nuclear Pharmacy, A Quick Glance, Boston Association ofRetail Druggists, Summer Meeting, Stevensville, NY, July 1977G. In Vitro Stability of Radiopharmaceuticals, Nuclear MedicineResearch Seminar. Harvard Medical School, Boston, Massachu-setts, June 1977H. Evaluation of Factors Involved in Radiolytic Decomposition ofRadiopharmaceuticals, American Pharmaceuticals Association,Academy of Pharmacy Practice, Section on Nuclear Pharmacy,Annual Meeting, New York, May 1977I. A Kinetic Treatment of Radiopharmaceutical Decomposition,American Pharmacy, Annual Meeting, New Orleans, Louisiana,April, 1976J. The Role of State Boards of Pharmacy in Nuclear PharmacyPractice, District 1 Annual Meeting of American Association ofColleges of Pharmacy and National Association of Boards of Pharmacy, Hyannis, Massachusetts, November 1976K. Radiopharmaceutics, A New Specialty in Pharmacy, Region 1Meeting, Student American Pharmaceutical Association, Boston,Massachusetts. November 1976ABSTRACTSA. Hotte, C.E., Vecchione, J.J., Ledig, C.B., Valeri, C.R., Callow,A.D. and Kahn, P.C.: Dosimetry of Autologous Baboon PlateletsLabeled with In-111 Oxine. Journal of Nuclear Medicine 20:685,1979B. Hotte, C.E., Vecchione, J.J., Ledig, C.B., Valeri, C.R., Callow,A.D. and Kahn, P.C.: A Sterile Technique for Labeling Plateletswith In-111 Oxine. American Pharmaceutical Association, Section on Nuclear Pharmacy, Annual Meeting, April 1979C. Wilcox, L.M., Keough, E.M., Connolly, R.J. and Hotte, C.E.: TheContribution of Blood Flow of the Anterior Ciliary Artery to theAnterior Segment. Investigative Ophthalmology and VisualScience, Supplement, April 1979D. Vecchione, J.J., Hotte, C.E., Ledig, C.B., et al: Circulation ofAutologous Baboon Platelets Labeled with In-111". AmericanHematological Society Annual Meeting, New Orleans, Louisiana,December 1978E. Ledig, C.B., Vecchione, J.J., Hotte, C.E., et al: A Model for theStudy of the Dynamic Sequence of Healing Patterns inReconstructed Arterial Surfaces. New England Vascular SocietyAnnual Meeting, Dixville Notch, New Hampshire, September 1978F. Connolly, R.J., Wilcox, L.M., Keough, E.M.., and Hotte, C.E.:Blood Flow to the Extraocular Muscles: A Comparative Study.Investigative Ophthalmology and Visual Science, Supplement,April 1979G. Hotte, C.E., Connolly, R.J., Wilcox, L.M., and Keough, E.M.: AComparative Study on Ocular Bllod Flow and the Role of theAnterior Ciliary Arteries. Investigative Ophthalmology and VisualScience, Supplement, April 1979PUBLICATIONSA. Keough, E.M., Wilcox, L.M., Connolly, R.J. and Hotte, C.E.:Comparative Ocular Blood Flow. Comp. Biochem. And Physiol.,68A:269-271, 1981B. Wilcox, L.M., Keough, E.M., Connolly, R.J. and Hotte, C.E.:Effect of Complete Tenotomy on Blood Flow to the AnteriorSegment of the Canine Eye. Investigations in Ophthalmology andVisual Science, 19:1355-1359, November 1980C. Wilcox, L.M., Keough, E.M., Connolly, R.J. and Hotte, C.E.:The Contribution of Blood Flow by the Anterior Ciliary Arteries tothe Anterior Segment in the Primate Eye. Exp. Eye Res. 30:167-174, 1980D. Callow, A.D., Ledig, C.B., OConnell, T.F., Kelly, J.J., Rosenthal,D., Korwin, S., Hotte, C.E., Kahn, P.C., Vecchione, J.J. andValeri, C.R.: A Primate Model for the Study of the Interaction ofIn-111 Baboon Platelets with Dacron Arterial Prosthesis, Ann.Surg. 191:362-366, 1980E. Vecchione, J.J., Meleragna, A.., Hotte, C.E., et al: The Use of In-111 Oxine to Study the Circulation and Distribution of BaboonPlatelets and Granulocytes, Proceedings, A State of the ArtSymposium on Radiolabeled Blood Cellular Elements - CurrentAccomplishments, Immediate Potential, Future Possibilities,Medical Multimedia Publications, New York, 1979F. Vecchione, J.J., Ledig, C.B., Hotte, C.E., et al: Circulation ofAutologous Baboon Platelets Labeled with In-111", Proc. Am. Soc.Heme. 175, 1978G. Hotte, C.E., Ice, R.D. and Flynn, G.L.: Radiolysis of I-131-O-Iodohippurate: A Kinetic Study, J. Label Comp and Radiopharm.17:715-725, 1978H. Hotte, C.E., and Ice, R.D.: In Vitro Stability of I-131-O-Iodohippurate, J. Nucl. Med. 20:441-447, 1979I. Lamson, M.L., Hotte, C.E., and Ice, R.D.: Practical GeneratorKinetics, Appendix B in Basics of Radiopharmacy, by Rhodes,B.B. and Howard, B.Y., C.V. Mosby Co., St. Louis, Missouri,1978. (Revised version of article of same title which originallyappeared in J. Nucl. Med. Tech., March, 1976)J. Hotte, C.E. and Ice, RD.: Use of Revised MIRD Equation forDosimetric Calculations in Physical Systems, Health Physics32:442-443, 1977K. Hotte, C.E.: The Role of State Boards of Pharmacy in NuclearPharmacy Practice, Proceedings, District #1, NABP/AACP,Hyannis, Massachusetts, November 5-7, 1977L. Hotte, C.E.,: A Determination of the Simutaneous Effects ofRadiolytic and Thermal Decomposition on RadiopharmaceuticalStability, Ph.D. Thesis, University of Michigan, August, 1976M. Lamson, M.L., Kirschner, A.S., Hotte, C.E., Lipsitz, E.L. and Ice,R.D.: Generator Produced 99m-TcO4: Carrier Free? Journal ofNuclear Medicine, 16:639-641, 1975N. Lamson, M.L., Hotte, C.E., and Ice, R.D..: Practical GeneratorKinetics, J. Nucl. Med. Tech., 4:21-27, 1975O. Hotte, C.E., and Ice, R.D.: Thermal and RadiolyticDecomposition of I-131-Iodocholestrol, Journal of NuclearMedicine, 15:38-41, 1974P. Hotte, C.E.,: Drug Therapy Tips, Michigan Medicine, 71-1004-1005, 1972Q. Hotte, C.E.: Postgraduate Medicine Report, Questions andAnswers, Michigan Medical Center Journal, 38:PHONE NUMBER AVAILABLE/pre> |
